Kinetics of immunological parameters in patients with malignant melanoma treated with hyperthermic isolated limb perfusion.

[1]  T. Kageshita,et al.  Increase in shedding of intercellular adhesion molecule-1 in human malignant melanoma cell lines treated with hyperthermia in vitro. , 1996, Pigment cell research.

[2]  J. Nakayama,et al.  Two Cases of Metastatic Malignant Melanoma of the Lower Limb Treated with Hyperthermic Isolated Limb Perfusion and Concomitant Infusion of Either Carboplatin or β‐Interferon , 1996, The Journal of dermatology.

[3]  J. Nakayama,et al.  Hyperthermic Isolated Limb Perfusion with Intra‐Arterial Administration of Carboplatin and/or Interferon‐β for the Treatment of Malignant Melanoma of the Leg , 1994, The Journal of dermatology.

[4]  J. Nakayama,et al.  Suppression of murine melanoma growth with a combination of microwave hyperthermia and local injection of interleukin 2 , 1994, The British journal of dermatology.

[5]  J. Nakayama,et al.  In situ detection of immunocompetent cells in murine B16 melanoma locally treated with interleukin-2 or microwaval hyperthermia. , 1993, Pigment cell research.

[6]  D. Coit.  The role of surgery in cutaneous malignant melanoma. , 1993, Cancer treatment and research.

[7]  L. Nathanson.  Current Research and Clinical Management of Melanoma , 1993, Cancer Treatment and Research.

[8]  N. Renard,et al.  High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Y. Hashimoto,et al.  T Cell Receptor‐independent Cell‐mediated Cytotoxicity by Nude Mouse Lymphokine‐activated Killer Cells , 1991, Japanese journal of cancer research : Gann.

[10]  J. Thomas,et al.  Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb , 1990, The British journal of surgery.

[11]  H. Stützer,et al.  The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma , 1988, Cancer.

[12]  Michael Loran Dustin,et al.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. , 1986, Journal of immunology.